Published in Trials on February 26, 2010
Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network. BMC Med (2010) 2.24
A systematic review of the quality of reporting in published smoking cessation trials for pregnant women: an explanation for the evidence-practice gap? Implement Sci (2014) 0.85
Centre selection for clinical trials and the generalisability of results: a mixed methods study. PLoS One (2013) 0.85
Conflicts of interest and critiques of the use of systematic reviews in policymaking: an analysis of opinion articles. Syst Rev (2014) 0.76
Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration. Int J Equity Health (2015) 0.76
Cluster Sampling Bias in Government-Sponsored Evaluations: A Correlational Study of Employment and Welfare Pilots in England. PLoS One (2016) 0.75
Evidence based medicine: what it is and what it isn't. BMJ (1996) 66.70
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83
The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med (2001) 37.70
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ (2001) 20.65
The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health (1998) 17.71
The hazards of scoring the quality of clinical trials for meta-analysis. JAMA (1999) 17.00
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87
Epidemiology and reporting characteristics of systematic reviews. PLoS Med (2007) 11.51
External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet (2005) 11.35
Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials (1995) 9.85
The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol (1998) 7.43
Evolution of China's response to HIV/AIDS. Lancet (2007) 7.34
What is missing from descriptions of treatment in trials and reviews? BMJ (2008) 7.33
Grey zones of clinical practice: some limits to evidence-based medicine. Lancet (1995) 6.15
Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. BMJ (2005) 5.65
Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA (1998) 4.73
Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ (2009) 4.48
Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess (1999) 4.45
The history and challenge of HIV prevention. Lancet (2008) 3.34
Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC Med Res Methodol (2008) 3.11
How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49
Review of external validity reporting in childhood obesity prevention research. Am J Prev Med (2008) 2.33
Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ (2008) 2.15
Behavior change intervention research in healthcare settings: a review of recent reports with emphasis on external validity. Am J Prev Med (2002) 2.08
Assessment of generalisability in trials of health interventions: suggested framework and systematic review. BMJ (2006) 2.02
Prevalence of smoking in 8 countries of the former Soviet Union: results from the living conditions, lifestyles and health study. Am J Public Health (2004) 1.87
How evidence-based are the recommendations in evidence-based guidelines? PLoS Med (2007) 1.60
Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev (2006) 1.36
Use of systematic reviews in clinical practice guidelines: case study of smoking cessation. BMJ (2001) 1.18
Measuring the quality of trials: the quality of quality scales. JAMA (1999) 1.11
Tobacco cessation in primary care: maximizing intervention strategies. Clin Med Res (2003) 1.09
The account for provider and center effects in multicenter interventional and surgical randomized controlled trials is in need of improvement: a review. J Clin Epidemiol (2008) 1.02
Quality of reporting internal and external validity data from randomized controlled trials evaluating stents for percutaneous coronary intervention. BMC Med Res Methodol (2009) 0.96
External validity reporting in prevention research. Am J Prev Med (2008) 0.92
Neglected external validity in reports of randomized trials: the example of hip and knee osteoarthritis. Arthritis Rheum (2009) 0.90
Applying the results of trials and systematic reviews to our individual patients. Evid Based Ment Health (2001) 0.82
Size isn't everything. Stat Med (2002) 0.80
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87
Comparison of registered and published primary outcomes in randomized controlled trials. JAMA (2009) 7.89
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (2014) 7.55
A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J (2003) 6.88
Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med (2014) 5.98
Health research funding agencies' support and promotion of knowledge translation: an international study. Milbank Q (2008) 4.87
Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA (2010) 4.56
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med (2015) 4.49
Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med (2009) 4.19
Public availability of results of trials assessing cancer drugs in the United States. J Clin Oncol (2013) 3.73
Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med (2008) 3.63
Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort study. PLoS Med (2012) 3.33
Taking healthcare interventions from trial to practice. BMJ (2010) 3.27
Challenges in evaluating surgical innovation. Lancet (2009) 2.86
Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J (2005) 2.83
Quality of reporting of noninferiority and equivalence randomized trials. JAMA (2006) 2.79
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry. Arthritis Rheum (2010) 2.68
Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study. Ann Intern Med (2011) 2.62
[Critical appraisal of medical literature: an essential tool to practice medicine]. Presse Med (2008) 2.53
Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med (2010) 2.52
What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J (2007) 2.52
Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J (2008) 2.51
Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical procedures. Ann Surg (2014) 2.48
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). Arthritis Rheum (2004) 2.44
Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment. Arthritis Rheum (2008) 2.41
High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe. J Clin Oncol (2005) 2.35
A computerized handheld decision-support system to improve pulmonary embolism diagnosis: a randomized trial. Ann Intern Med (2009) 2.27
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis (2009) 2.20
Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet (2008) 2.03
Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med (2013) 2.02
Lack of head-to-head trials and fair control arms: randomized controlled trials of biologic treatment for rheumatoid arthritis. Arch Intern Med (2012) 1.95
The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: a systematic review. Ann Surg (2006) 1.91
Splint for base-of-thumb osteoarthritis: a randomized trial. Ann Intern Med (2009) 1.86
Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. PLoS Med (2013) 1.78
Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med (2007) 1.77
Reporting of sample size calculation in randomised controlled trials: review. BMJ (2009) 1.76
A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus. J Clin Epidemiol (2005) 1.74
Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS (2004) 1.73
Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials. J Clin Epidemiol (2004) 1.71
Descriptions of non-pharmacological interventions in clinical trials. BMJ (2013) 1.59
The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort. J Rheumatol (2009) 1.59
The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases. Blood (2009) 1.59
Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis. JAMA (2003) 1.58
Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 1.57
Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trial. J Rheumatol (2007) 1.57
Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients. Cochrane Database Syst Rev (2014) 1.56
Comparison of intervention effects in split-mouth and parallel-arm randomized controlled trials: a meta-epidemiological study. BMC Med Res Methodol (2014) 1.54
Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis. Eur Heart J (2010) 1.53
Bacteremia in patients receiving TNF-alpha antagonists--a prospective multicenter study. J Infect (2013) 1.52
Beneficial effects of information leaflets before spinal steroid injection. Joint Bone Spine (2002) 1.51
Size-adjusted left ventricular outflow tract diameter reference values: a safeguard for the evaluation of the severity of aortic stenosis. J Am Soc Echocardiogr (2009) 1.46
Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants. BMC Med (2012) 1.46
Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies--the Pre-Optimon study. Contemp Clin Trials (2010) 1.46
Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ (2005) 1.44
The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine (2007) 1.44
Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort. J Rheumatol (2013) 1.42
Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registry. Clin Exp Rheumatol (2012) 1.42
Missing data in randomized controlled trials of rheumatoid arthritis with radiographic outcomes: a simulation study. Arthritis Rheum (2008) 1.40
Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy. Ann Rheum Dis (2012) 1.39
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis (2011) 1.37
Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders. J Rheumatol (2007) 1.33
Survival after bilateral versus single-lung transplantation for idiopathic pulmonary fibrosis. Ann Intern Med (2009) 1.31
Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review. PLoS Med (2006) 1.31
Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review. Am J Med Sci (2007) 1.31
Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS (2007) 1.28
Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study. BMJ (2012) 1.28
Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions. BMC Med (2012) 1.23
Influence of blinding sequence of radiographs on the reproducibility and sensitivity to change of joint space width measurement in knee osteoarthritis. Arthritis Care Res (Hoboken) (2010) 1.23
Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review. BMJ (2013) 1.22
Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment. Crit Rev Oncol Hematol (2009) 1.22
Preventing bias in cluster randomised trials. PLoS Med (2009) 1.22
Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ (2013) 1.21
Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation (2009) 1.21
Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed. J Clin Epidemiol (2010) 1.21
Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries. Rheumatology (Oxford) (2011) 1.20
Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues. J Rheumatol (2005) 1.19
A priori postulated and real power in cluster randomized trials: mind the gap. BMC Med Res Methodol (2005) 1.19
Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. CMAJ (2013) 1.19
Computer-generated reminders delivered on paper to healthcare professionals; effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2012) 1.15
Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. J Clin Hypertens (Greenwich) (2012) 1.15
Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis (2012) 1.14
Uncertainty in Treatment Rankings: Reanalysis of Network Meta-analyses of Randomized Trials. Ann Intern Med (2016) 1.14
Determinants of success for computerized clinical decision support systems integrated in CPOE systems: a systematic review. AMIA Annu Symp Proc (2006) 1.13
Use of trial register information during the peer review process. PLoS One (2013) 1.13